Cargando…
Molecular imaging reveals biodistribution of P-cadherin LP-DART bispecific and trafficking of adoptively transferred T cells in mouse xenograft model
P-cadherin-LP-DART is a bispecific antibody targeting P-cadherin expressed on the tumor cells and CD3 on the T-cells. Previously we demonstrated the development and efficacy of P-cadherin-LP-DART in in vitro and in vivo models. Here, we evaluated the three pillars: exposure, targeting specificity an...
Autores principales: | Gupta, Vijay R., Root, Adam, Fisher, Timothy, Norberg, Rand, David, John, Clark, Tracey, Cohen, Justin, May, Chad, Giddabasappa, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170501/ https://www.ncbi.nlm.nih.gov/pubmed/32341754 http://dx.doi.org/10.18632/oncotarget.27544 |
Ejemplares similares
-
A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART(®)
por: Betts, Alison, et al.
Publicado: (2019) -
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
por: Root, Adam R., et al.
Publicado: (2016) -
Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART(®) Molecules
por: Tuyishime, Marina, et al.
Publicado: (2021) -
Biodistribution and Trafficking of Hydrogel Nanoparticles in Adult Mosquitoes
por: Paquette, Cynthia C. H., et al.
Publicado: (2015) -
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
por: Berezhnoy, Alexey, et al.
Publicado: (2020)